{"id":"CHEMBL107400","canonicalSmiles":"Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1","inchiKey":"QNAZTOHXCZPOSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOBETIROME","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GC-1","QRX-431","Sobetirome"],"crossReferences":{"drugbank":["DB07425"],"chEBI":["79988"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1089962","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O","inchiKey":"RNBGYGVWRKECFJ-ZXXMMSQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRUCTOSE 1,6-DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fructose 1,6-diphosphate","Fructose-1,6-Diphosphate"],"crossReferences":{"Wikipedia":["Fructose_1,6-bisphosphate"],"chEBI":["40595"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL109420","canonicalSmiles":"CC(=O)N(C)Cc1cc(C(=O)N(C)Cc2cc3ccccc3n2C)ccc1N","inchiKey":"AWTBJNJPBKTHEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1094304","canonicalSmiles":"CC[C@H](CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1","inchiKey":"NDUVSANREQEDRE-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOMOUCINE II","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olomoucine Ii"],"crossReferences":{"drugbank":["DB04662"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL113150","canonicalSmiles":"CCCCCCCCCCCCCC[N+](C)(C)C.[Br-]","inchiKey":"CXRFDZFCGOPDTD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CETRIMIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1180003","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anglian","Bactrian","Bansor","Ceanel","Cetavlex","Cetavlon","Cetavlon pc","Cradocap","Medicaid","Richmond","Toracsol"],"synonyms":["Cetrimide","Tetradonium bromide"],"crossReferences":{"DrugCentral":["4360"],"PubChem":["144205880","144212384","170466276"],"Wikipedia":["Cetrimonium_bromide"],"chEBI":["3565"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1149","canonicalSmiles":"C[N+](C)(C)C[C@H](O)CC(=O)[O-]","inchiKey":"PHIQHXFUZVPYII-ZCFIWIBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOCARNITINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicarnesine","Biocarn","Carnitor","Carnitor sf","Levocarnitine","Vitamin Bt"],"synonyms":["Carnitine","Levocarnitine","Levocarnitine chloride"],"crossReferences":{"DailyMed":["levocarnitine"],"PubChem":["56320718"],"drugbank":["DB00583"],"chEBI":["16347"]},"count":23,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 23 investigational indications."}
{"id":"CHEMBL1159902","canonicalSmiles":"Nc1nc2ncc(COP(=O)(O)O)nc2c(=O)[nH]1","inchiKey":"AJXFJEHKGGCFNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6-Hydroxymethylpterin Monophosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-Hydroxymethylpterin Monophosphate"],"crossReferences":{"drugbank":["DB03592"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200501","canonicalSmiles":"CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O","inchiKey":"IKDXDQDKCZPQSZ-JHYYTBFNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GOSERELIN ACETATE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201247","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Novgos","Zoladex","Zoladex la"],"synonyms":["Goserelin Acetate","Goserelin acetate"],"crossReferences":{"DailyMed":["goserelin%20acetate"]},"count":13,"approvedIndications":["MONDO_0007254","EFO_0000305"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","MONDO_0008170","MONDO_0007254","MONDO_0000521","MONDO_0002087","EFO_0000305","MONDO_0008315","EFO_0001663","EFO_0000195","EFO_0000304","MONDO_0002158","EFO_0006861","EFO_0000731","EFO_0000673","MONDO_0024880","EFO_0003922"],"count":16},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for breast cancer and breast carcinoma and has 11 investigational indications."}
{"id":"CHEMBL1200586","canonicalSmiles":"CCCNC(C)C(=O)Nc1ccccc1C.Cl","inchiKey":"BJPJNTKRKALCPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRILOCAINE HYDROCHLORIDE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1194","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citanest","Citanest plain","Citanest plain dental","Prilocaine hydrochloride"],"synonyms":["ASTRA 1512","L-67","Prilocaine hydrochloride","Propitocaine hydrochloride"],"crossReferences":{"DailyMed":["prilocaine%20hydrochloride"],"PubChem":["11532855","144204064","170464697","50106902"],"chEBI":["32053"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1965."}
{"id":"CHEMBL1200588","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1.Cl","inchiKey":"AUODDLQVRAJAJM-XJQDNNTCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN HYDROCHLORIDE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cleocin","Cleocin hydrochloride","Clindamycin hydrochloride","Dalacin c"],"synonyms":["Clindamycin HCl","Clindamycin hydrochloride","U-25179E"],"crossReferences":{"DailyMed":["clindamycin%20hydrochloride"],"PubChem":["144204142"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200676","drugType":"Small molecule","blackBoxWarning":false,"name":"CHROMIC PHOSPHATE P 32","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110568","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chromphosphotope","Phosphocol p32"],"synonyms":["32p","Chromic phosphate p 32","Chromic phosphate p-32","Phosphorous (32p) chromicphosphate colloid"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1200852","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+]","inchiKey":"HCTVWSOKIJULET-LQDWTQKMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN V POTASSIUM","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL615","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beepen VK","Beepen-vk","Betapen-vk","Ledercillin vk","Pen-vee k","Penapar-vk","Penicillin Vk","Penicillin v potassium","Penicillin-vk","Pfizerpen vk","Phenoxymethylpenicillin K","Uticillin vk","V-Cillin-K","V-cillin k","Veetids","Veetids '125'","Veetids '250'","Veetids '500'"],"synonyms":["Penicillin potassium phenoxymethyl","Penicillin v potassium","Phenoxymethylpenicillin potassium"],"crossReferences":{"DailyMed":["penicillin%20v%20potassium"],"PubChem":["144209374","144213231","26757422"],"chEBI":["7967"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958."}
{"id":"CHEMBL1201080","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cl","inchiKey":"YLCCEQZHUHUYPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOPRIM HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL22","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Primsol"],"synonyms":["Trimethoprim hydrochloride"],"crossReferences":{"DailyMed":["trimethoprim%20hydrochloride"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and has 1 investigational indication."}
{"id":"CHEMBL1201284","canonicalSmiles":"C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12","inchiKey":"VDHAWDNDOKGFTD-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINACALCET","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sensipar"],"synonyms":["AMG 073","AMG-073","AMG073","Cinacalcet","KRN-1493","KRN1493"],"crossReferences":{"DailyMed":["cinacalcet%20hydrochloride"],"PubChem":["124893630","50125742"],"Wikipedia":["Cinacalcet"],"drugbank":["DB01012"],"chEBI":["48390"]},"childChemblIds":["CHEMBL1200776"],"count":7,"approvedIndications":["EFO_0005754"],"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_0001072","EFO_1001173","Orphanet_437","EFO_0008519","EFO_0008506","EFO_0003884","EFO_0000673","EFO_0003882","EFO_1001152","EFO_0005754"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for parathyroid disease and has 6 investigational indications."}
{"id":"CHEMBL1201294","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1","inchiKey":"HYPPXZBJBPSRLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENOXYLATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphenoxylate"],"crossReferences":{"DailyMed":["diphenoxylate%20hydrochloride"],"PubChem":["50113007"],"Wikipedia":["Diphenoxylate"],"drugbank":["DB01081"],"chEBI":["4639"]},"childChemblIds":["CHEMBL1200665"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0004798"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201451","drugType":"Protein","blackBoxWarning":false,"name":"ALBUMIN HUMAN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albumin (Human)","Albuminar-5","Buminate","Optison","Plasbumin"],"synonyms":["Albumin","Albumin human"],"count":24,"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 24 investigational indications."}
{"id":"CHEMBL1201460","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"DALTEPARIN SODIUM","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fragmin","Low liquemine"],"synonyms":["Dalteparin","Dalteparin sodium","FR-860","HEPARIN FRAGMENT KABI 2165","KABI-2165"],"crossReferences":{"DailyMed":["dalteparin%20sodium"]},"count":23,"approvedIndications":["EFO_0003907","HP_0004419"],"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0006834","Orphanet_232","EFO_0000681","MONDO_0008170","EFO_0004286","MONDO_0007254","EFO_0009315","MONDO_0019514","EFO_0000350","EFO_1002048","MONDO_0008315","EFO_0002950","EFO_1001951","EFO_0000311","HP_0001907","EFO_1000954","EFO_1001459","EFO_0000712","EFO_0003884","MONDO_0008903","EFO_0003907","EFO_0001378","HP_0004419","MONDO_0043510","HP_0004418","EFO_1000158"],"count":27},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for recurrent thrombophlebitis and deep vein thrombosis and has 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201476","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"ENOXAPARIN SODIUM","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clexane","Enoxaparin sodium","Enoxaparin sodium (preservative free)","Lovenox","Lovenox (preservative free)"],"synonyms":["Enoxaparin","Enoxaparin sodium","Enoxaparin sodium salt","PK 10169","PK-10169","RP 54563","RP-54563"],"crossReferences":{"DailyMed":["enoxaparin%20sodium"],"DrugCentral":["4879"]},"count":31,"approvedIndications":["MONDO_0000831","EFO_0003907","EFO_0000612","HP_0004419","HP_0004936"],"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000275","EFO_0005669","EFO_0000495","EFO_0003964","MONDO_0001416","EFO_0005681","HP_0030242","EFO_0008585","EFO_0000544","EFO_1001375","EFO_0003144","EFO_0000712","HP_0004420","EFO_0004255","EFO_0004616","HP_0004419","HP_0004936","EFO_0002618","EFO_0000616","EFO_0000545","HP_0002140","EFO_0002916","MONDO_0008170","EFO_0001645","EFO_0004286","EFO_0007443","EFO_0001073","EFO_0003060","EFO_0000311","EFO_1000954","HP_0001907","MP_0001914","EFO_0001422","MP_0001845","MONDO_0100096","MONDO_0000831","EFO_0003827","EFO_0001359","EFO_0000702","EFO_0000574","EFO_0003907","EFO_0008583","EFO_0000612","EFO_0009557","EFO_0009314","EFO_0000668","EFO_0005672"],"count":48},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 5 approved and 26 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201479","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYETHYLENE GLYCOL 3350","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glycolax","Miralax","Polyethylene glycol 3350"],"synonyms":["Polyethylene glycol 3350"],"crossReferences":{"DailyMed":["polyethylene%20glycol%203350"]},"count":10,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for constipation and has 9 investigational indications."}
{"id":"CHEMBL1201609","drugType":"Protein","blackBoxWarning":false,"name":"CORTICOTROPIN ZINC HYDROXIDE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cortrophin zinc acth","Cortrophin-zinc"],"synonyms":["Corticotrophin zinc hydroxide","Corticotropin zinc hydroxide","Corticotropin-zinc hydroxide"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1955."}
{"id":"CHEMBL1201666","drugType":"Protein","blackBoxWarning":false,"name":"LEPIRUDIN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Refludan"],"synonyms":["Hirudin lepirudin","Lepirudin","Lepirudin Recombinant","Lepirudin recombinant"],"crossReferences":{"DrugCentral":["2995"],"Wikipedia":["Lepirudin"]},"count":3,"approvedIndications":["MONDO_0000831","HP_0004419"],"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["MONDO_0000831","MONDO_0008903","HP_0004419","HP_0001873"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for thrombotic disease and recurrent thrombophlebitis and has 1 investigational indication."}
{"id":"CHEMBL1201692","drugType":"Protein","blackBoxWarning":false,"name":"FOLLITROPIN ALFA","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bemfola","Follistim","Follistim aq","Gonal-f","Gonal-f rff","Gonal-f rff redi-ject","Ovaleap","Puregon"],"synonyms":["Follitropin alfa","Follitropin alfa/beta","Follitropin beta","Fsh (menotropins)","Human FSH"],"crossReferences":{"DailyMed":["follitropin%20alfa/beta"],"DrugCentral":["4928"]},"count":4,"linkedTargets":{"rows":["ENSG00000170820"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0008560","MONDO_0002775","EFO_0000660"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 4 investigational indications."}
{"id":"CHEMBL1201749","canonicalSmiles":"CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"WYQPLTPSGFELIB-JTQPXKBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLUPREDNATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Durezol"],"synonyms":["Difluprednate","W 6309","W-6309"],"crossReferences":{"DailyMed":["difluprednate"],"PubChem":["144206181","56422387","856020"],"Wikipedia":["Difluprednate"],"drugbank":["DB06781"],"chEBI":["31485"]},"count":4,"approvedIndications":["EFO_1000811"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001231","MP_0001845","EFO_1000811","EFO_1001082","EFO_0001059","EFO_1000879","EFO_1000906"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for anterior uveitis and has 3 investigational indications."}
{"id":"CHEMBL1213470","canonicalSmiles":"OC[C@H]1N/C(=N/O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"VBXHGXTYZGYTQG-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213470","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02376"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1215661","canonicalSmiles":"N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)cccc12","inchiKey":"AQRLDDAFYYAIJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUVANSERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 390920","EMD-281014","EMD-390920","LSN-2422347","LSN2422347","LY-2420586","LY-2422347","LY-2422347 FREE BASE","LY2420586","LY2422347","Ly2422347","Pruvanserin"],"crossReferences":{"Wikipedia":["Pruvanserin"],"drugbank":["DB13094"]},"childChemblIds":["CHEMBL2104980"],"count":1,"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1231700","canonicalSmiles":"C[N+](C)(C)CCOP(=O)(O)OP(=O)([O-])OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O","inchiKey":"RZZPDXZPRHQOCG-OJAKKHQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CITICOLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytidine-5'-Diphosphocholine"],"crossReferences":{"drugbank":["DB12153"],"chEBI":["16436"]},"childChemblIds":["CHEMBL1256994"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1232391","canonicalSmiles":"O[C@H](CS)[C@@H](O)CS","inchiKey":"VHJLVAABSRFDPM-ZXZARUISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232391","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01692"],"chEBI":["17456"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232918","canonicalSmiles":"O=C[C@H](O)COP(=O)(O)O","inchiKey":"LXJXRIRHZLFYRP-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232918","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02263"],"chEBI":["29052"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234871","canonicalSmiles":"C=CCNc1ccccc1","inchiKey":"LQFLWKPCQITJIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234871","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02870"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235110","canonicalSmiles":"Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)ncc2C(N)=O)c1","inchiKey":"NZNTWOVDIXCHHS-LSDHHAIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235110","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08361"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235999","canonicalSmiles":"Nc1ccccc1CO","inchiKey":"VYFOAVADNIHPTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISATOIC ANHYDRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isatoic Anhydride"],"crossReferences":{"drugbank":["DB03058"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237068","canonicalSmiles":"O.OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"XVCHNXZRPZGVJA-MILSHCHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTULOSE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL296306","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Acilac","Cephulac","Cholac","Chronulac","Constilac","Constulose","Duphalac","Enulose","Evalose","Generlac","Heptalac","Lactulose","Laxilose","Portalac"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237132","canonicalSmiles":"CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl","inchiKey":"KPBZROQVTHLCDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEVIDIPINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cleviprex"],"synonyms":["Clevidipine","Clevidipine butyrate"],"crossReferences":{"DailyMed":["clevidipine"],"PubChem":["170466066"],"drugbank":["DB04920"]},"count":4,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_1001031","EFO_0004273","EFO_0005669","EFO_0000319","EFO_0001666","EFO_0004264","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL1255582","canonicalSmiles":"CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1","inchiKey":"KXSUAWAUCNFBQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIPAMEZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fipamezole"],"crossReferences":{"drugbank":["DB06585"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1257","canonicalSmiles":"FC(F)OC(F)(F)C(F)Cl","inchiKey":"JPGQOUSTVILISH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENFLURANE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enflurane","Ethrane"],"synonyms":["ANESTHETIC COMPOUND NO. 347","Anesthetic Compound No. 347","Enflurane"],"crossReferences":{"PubChem":["144207364","50112675"],"Wikipedia":["Enflurane"],"drugbank":["DB00228"],"chEBI":["4792"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972."}
{"id":"CHEMBL1257073","canonicalSmiles":"O=C(NN1C(=O)[C@H]2[C@H]3C=C[C@H]([C@@H]4C[C@H]34)[C@H]2C1=O)c1ccc(C(F)(F)F)cc1","inchiKey":"CSKDFZIMJXRJGH-VWLPUNTISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECOVIRIMAT","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tpoxx"],"synonyms":["SIGA-246","ST 246","ST-246","Tecovirimat"],"crossReferences":{"DailyMed":["tecovirimat"],"drugbank":["DB12020"]},"count":1,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for viral disease."}
{"id":"CHEMBL1278118","canonicalSmiles":"COc1cc(OC)cc(N2CCN(C(=O)Nc3nc4cc(F)ccc4nc3OC)CC2)c1","inchiKey":"KAKPGJJRYRYSTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUPINOXIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RX-5902","Rx-5902","Supinoxin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1286","canonicalSmiles":"CC[C@@H](C(N)=O)N1CCCC1=O","inchiKey":"HPHUVLMMVZITSG-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVETIRACETAM","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desitrend","Elepsia xr","Keppra","Keppra xr","Levetiracetam","Levetiracetam in sodium chloride","Matever","Spritam"],"synonyms":["AGB-101","Levetiracetam","N03AX14","UCB 22059","UCB L059","UCB-22059","UCB-L059"],"crossReferences":{"DailyMed":["levetiracetam"],"PubChem":["26719810","90341134"],"Wikipedia":["Levetiracetam"],"drugbank":["DB01202"],"chEBI":["6437"]},"count":39,"approvedIndications":["HP_0002069","EFO_0000474","HP_0001250"],"linkedTargets":{"rows":["ENSG00000159164","ENSG00000148408"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004777","EFO_0002610","EFO_0004262","EFO_0004280","Orphanet_232","HP_0000726","EFO_0000249","EFO_0005669","EFO_0003829","MONDO_0002046","EFO_0009562","HP_0100543","EFO_0000474","Orphanet_1945","MONDO_0002050","EFO_0000289","EFO_0004263","EFO_0000712","EFO_0000326","EFO_0006510","EFO_0004242","EFO_0005230","EFO_0000692","HP_0002121","HP_0002069","EFO_0008526","EFO_0002508","HP_0000473","EFO_1000904","EFO_0000222","EFO_0005407","MONDO_0015643","EFO_0001358","HP_0001250","HP_0002381","EFO_0003843","EFO_0000621","EFO_0003885","EFO_0000713","EFO_0004895","Orphanet_93958","EFO_0005611","EFO_0007262","EFO_0004270","EFO_0003833","EFO_0000519","EFO_0003108"],"count":48},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 36 investigational indications."}
{"id":"CHEMBL1326247","canonicalSmiles":"CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)C[C@@H](O)C(=O)O.O=C(O)C[C@@H](O)C(=O)O","inchiKey":"GTHHLZDYRHLACN-WRCJVSMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1326247","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1378","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113031"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1365278","canonicalSmiles":"C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C.[Na+]","inchiKey":"FHHPUSMSKHSNKW-SMOYURAASA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1365278","maximumClinicalTrialPhase":0,"parentId":"CHEMBL406393","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204617","144208094","17389068","93576906"],"chEBI":["9177"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1366","drugType":"Small molecule","blackBoxWarning":true,"name":"AURANOFIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ridaura"],"synonyms":["Auranofin","SK&F 39162","SK&F-39162","SK-39162"],"crossReferences":{"DailyMed":["auranofin"],"DrugCentral":["4122"],"Wikipedia":["Auranofin"],"chEBI":["2922"]},"count":13,"approvedIndications":["EFO_0000685","EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for rheumatoid arthritis and rheumatic disease and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL140","canonicalSmiles":"COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O","inchiKey":"VFLDPWHFBUODDF-FCXRPNKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL140","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["104171337","124882763","124882764","124882767","144204354","144205058","144208314","17389087","50104137","50104138","56422380","855880","91276"],"drugbank":["DB11672"],"chEBI":["3962"]},"childChemblIds":["CHEMBL1916041"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1410877","canonicalSmiles":"Clc1ccc([C@H](Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1","inchiKey":"JLGKQTAYUIMGRK-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARASERTACONAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arasertaconazole"],"crossReferences":{"PubChem":["11112882"],"chEBI":["83685"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1413199","canonicalSmiles":"O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1","inchiKey":"JYGLAHSAISAEAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENADIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diphenadione","Diphenylacetylindandione"],"crossReferences":{"PubChem":["144205446","170466609","26754631","29216237"],"Wikipedia":["Diphenadione"],"drugbank":["DB13347"],"chEBI":["81896"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1433","canonicalSmiles":"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21","inchiKey":"JBIWCJUYHHGXTC-AKNGSSGZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXYCYCLINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vibramycin"],"synonyms":["Doxycycline","GS-3065"],"crossReferences":{"DailyMed":["doxycycline","doxycycline%20hyclate"],"PubChem":["26755247","90340791"],"Wikipedia":["Doxycycline"],"drugbank":["DB00254"],"chEBI":["50845"]},"childChemblIds":["CHEMBL1200699","CHEMBL2364574","CHEMBL1256723","CHEMBL1200567","CHEMBL2106418","CHEMBL3989740"],"count":2,"approvedIndications":["EFO_0000771","EFO_0000544"],"linkedTargets":{"rows":["ENSG00000196611","ENSG00000137745","ENSG00000118113","ENSG00000137673"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000842","EFO_0000365","EFO_0007486","EFO_0000756","EFO_0000249","EFO_0009536","EFO_0007272","EFO_0005952","EFO_0003102","Orphanet_85443","EFO_1001951","EFO_0007205","EFO_0000771","EFO_1001459","EFO_0002506","EFO_0000096","EFO_0000544","EFO_1001898","EFO_0007357","EFO_1000961","EFO_1000785","EFO_0008517","MONDO_0002635","EFO_0002618","EFO_0007504","EFO_0002687","EFO_1000906","HP_0000964","MONDO_0022113","EFO_1001466","EFO_0000701","Orphanet_3389","EFO_0000662","EFO_0004607","Orphanet_558","EFO_0000384","EFO_0003878","EFO_1001388","EFO_1000760","EFO_0007460","MP_0001914","MONDO_0100096","EFO_0007430","HP_0000130","EFO_1001177","EFO_0000574","EFO_0009659","EFO_1001051","EFO_0000341","EFO_1001312","Orphanet_314701","EFO_0009637","EFO_0004214","EFO_0001365","EFO_1001984","EFO_0000768","EFO_0002913","Orphanet_586","EFO_0000274","Orphanet_85451","EFO_0005622","EFO_0009425","EFO_0008510","HP_0002013","EFO_0000778","EFO_0000616","EFO_1001788","HP_0001945","EFO_1001875","EFO_0003770","EFO_0000319","Orphanet_271861","HP_0001250","EFO_0003894","EFO_0003843","EFO_1000941","EFO_0003060","EFO_0000311","EFO_0003106","EFO_0003885","EFO_0000649","EFO_0000764","Orphanet_774","EFO_0000199","EFO_1000781","EFO_0000612","MONDO_0043510","EFO_0001067","MONDO_0024880","EFO_0007480","EFO_0003895"],"count":92},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for infection and bacterial disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1456","canonicalSmiles":"COc1c(C)c2c(c(O)c1C/C=C(\\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2","inchiKey":"RTGDFNSFWBGLEC-SYZQJQIISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MYCOPHENOLATE MOFETIL","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arzip","Cellcept","Mycophenolate mofetil","Myfenax"],"synonyms":["Mycophenolate mofetil","Mycophenolic acid 2-(4-morpholinyl)ethyl ester","RS-61443"],"crossReferences":{"DailyMed":["mycophenolate%20mofetil","mycophenolate%20mofetil%20hydrochloride"],"PubChem":["144205239","170464859","29215409"],"Wikipedia":["Mycophenolate_mofetil"],"drugbank":["DB00688"],"chEBI":["8764"]},"childChemblIds":["CHEMBL1200955"],"count":111,"linkedTargets":{"rows":["ENSG00000106348","ENSG00000178035"],"count":2},"linkedDiseases":{"rows":["EFO_0000401","EFO_0000681","EFO_0005952","EFO_1001345","EFO_0006803","EFO_1000318","MONDO_0015760","EFO_0000339","EFO_0000096","EFO_0002690","EFO_1000956","Orphanet_3319","EFO_0003884","EFO_0000676","EFO_0004991","Orphanet_42738","EFO_0000198","MONDO_0013730","EFO_0002618","EFO_0009012","MONDO_0019465","EFO_0001642","EFO_1000309","EFO_0000384","Orphanet_567","EFO_1001231","MONDO_0009453","EFO_0000404","EFO_0003032","MONDO_0044889","MONDO_0019472","EFO_0000574","EFO_0004256","EFO_0001378","Orphanet_231214","EFO_1000550","EFO_0001062","Orphanet_84","EFO_0003086","MONDO_0044903","EFO_0001365","EFO_0007451","EFO_1001465","EFO_0000255","MONDO_0003541","EFO_0002430","EFO_0005676","MONDO_0002898","Orphanet_79264","EFO_0007208","EFO_0004826","EFO_0000183","EFO_0005140","Orphanet_447","EFO_1000388","HP_0012115","EFO_0000616","EFO_1001779","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","MONDO_0018170","EFO_0000319","MONDO_0019469","EFO_0004599","EFO_0000537","EFO_0003885","EFO_0003896","Orphanet_79292","EFO_0005297","EFO_0000764","EFO_0007359","EFO_0006927","MONDO_0002367","MONDO_0018906","Orphanet_309015","MONDO_0000873","EFO_0003777","Orphanet_183660","EFO_0004274","Orphanet_848","EFO_0000565","EFO_0000309","EFO_0004251","EFO_0007160","HP_0001871","EFO_0000389","MONDO_0019088","EFO_0000182","EFO_0000330","EFO_0004255","EFO_0004244","EFO_0000253","EFO_0007196","EFO_1000785","EFO_0004719","EFO_0009441","EFO_0005761","EFO_1001857","EFO_0000220","EFO_0004236","EFO_0004194","MONDO_0044881","EFO_1000784","EFO_0002429","MONDO_0019474","Orphanet_811","MP_0001845","MONDO_0021193","EFO_0001359","EFO_0002428","EFO_1001051","EFO_0000699","EFO_0009878","EFO_1000102","MONDO_0019471","Orphanet_232","EFO_1000965","DOID_13406","EFO_0008507","EFO_1001469","HP_0001915","EFO_1002048","EFO_1000690","Orphanet_906","EFO_0004254","EFO_0003047","EFO_0000717","EFO_0000685","EFO_0000621","EFO_0000311","MONDO_0001705","EFO_0000211","EFO_0000095","EFO_0001421","EFO_1000560"],"count":137},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 111 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1484","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1","inchiKey":"ZBBHBTPTTSWHBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICARDIPINE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nicardipine"],"crossReferences":{"DailyMed":["nicardipine%20hydrochloride"],"PubChem":["104171201","124880905","144203762","170465173","26755701","26755702","50111158","50111159","90340664"],"Wikipedia":["Nicardipine"],"drugbank":["DB00622"],"chEBI":["7550"]},"childChemblIds":["CHEMBL1200326"],"count":7,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["HP_0000303","HP_0002140","EFO_0001645","EFO_0009846","EFO_0005669","EFO_0000319","EFO_1000994","EFO_0000537","EFO_0000713","EFO_0000712","EFO_0003833","EFO_0000668","EFO_0007490","EFO_0005672","EFO_0004282"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for cardiovascular disease and has 6 investigational indications."}
{"id":"CHEMBL1504","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"YNDXUCZADRHECN-JNQJZLCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAMCINOLONE ACETONIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adcortyl","Adcortyl in orabase","Allernaze","Aristocort","Aristocort a","Aristogel","Audicort","Aureocort","Azmacort","Flutex","Gppe ear dps cap","Gppe ear oint","Kenacort","Kenalog","Kenalog in orabase","Kenalog-10","Kenalog-40","Kenalog-80","Kenalog-h","Nasacort","Nasacort allergy 24 hour","Nasacort aq","Nasacort hfa","Nystadermal","Oracort","Oralone","Pevaryl t.c.","Remiderm","Remotic","Silderm","Tri-Nasal","Tri-adcortyl","Triacet","Triacort","Triamcinolone acetonide","Triamcinolone acetonide in absorbase","Triatex","Triderm","Triesence","Trivaris","Trymex","Vetalog","Zilretta"],"synonyms":["FX-006","FX006","Kenacourt","NSC-21916","Triamcinolone Acetonide","Triamcinolone acetonide"],"crossReferences":{"DailyMed":["triamcinolone%20acetonide"],"PubChem":["144204436","144208993","144213331","170464660","29215012","56423119","855857"],"Wikipedia":["Triamcinolone_acetonide"],"chEBI":["71418"]},"count":42,"approvedIndications":["EFO_0005854","EFO_1001896","EFO_0002506","EFO_0004274","EFO_0003843","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0004683","EFO_0010822","EFO_1000809","EFO_0004274","MONDO_0002959","EFO_0009322","EFO_1001129","EFO_1000706","EFO_0000497","EFO_0002506","MONDO_0002471","EFO_1000786","EFO_1001898","EFO_0004616","EFO_0004208","EFO_0008517","EFO_1001250","EFO_0004719","EFO_0005854","MONDO_0022113","EFO_0007363","HP_0001742","HP_0030016","EFO_1001119","EFO_1001231","EFO_1000986","EFO_0004192","EFO_0000270","EFO_0000516","EFO_0007415","EFO_0003943","EFO_0001059","EFO_1001896","MONDO_0003005","EFO_0001365","EFO_0000693","EFO_0008507","HP_0010450","EFO_0000274","EFO_0009606","HP_0030834","EFO_0004212","EFO_0004238","EFO_0009321","EFO_1001417","EFO_0007490","EFO_0008521","EFO_1000616","EFO_1001157","EFO_0003770","EFO_1001054","EFO_0003843","EFO_1000941","EFO_0004229","EFO_0009485","EFO_0000706","MONDO_0004857","EFO_0003956"],"count":58},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 6 approved and 36 investigational indications."}
{"id":"CHEMBL150894","canonicalSmiles":"CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3","inchiKey":"MLIFNJABMANKEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-5214","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-5214","Cep-5214"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1534525","canonicalSmiles":"COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C.Cl.Cl","inchiKey":"MTJLQTFHJIHXIX-GDUXWEAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIBEFRADIL DIHYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL45816","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," European Union"," Germany"," Ireland"," Malasia"],"classes":["Cardiotoxicity"],"year":1998},"tradeNames":["Posicor"],"synonyms":["Mibefradil dihydrochloride","RO 40-5967/001"],"crossReferences":{"PubChem":["144204795","170466110","50106572"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in United States,  European Union,  Germany,  Ireland and  Malasia initially in 1998 due to Cardiotoxicity."}
{"id":"CHEMBL1580","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O","inchiKey":"FPVKHBSQESCIEP-JQCXWYLXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTOSTATIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nipent","Pentostatin"],"synonyms":["CI-825","NSC-218321","Nipent","PD 81565","PD-81565","Pentostatin","YK-176"],"crossReferences":{"DailyMed":["pentostatin"],"PubChem":["124893765","144206967"],"Wikipedia":["Pentostatin"],"drugbank":["DB00552"]},"count":10,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000196839"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","MONDO_0013730","EFO_0000616","EFO_1000956","EFO_0000095","Orphanet_232","EFO_0000574","MONDO_0002367","EFO_0004599","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for neoplasm and cancer and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1581","canonicalSmiles":"CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC","inchiKey":"IPVQLZZIHOAWMC-QXKUPLGCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERINDOPRIL","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["MCN-A-2833","Perindopril","S-9490"],"crossReferences":{"DailyMed":["perindopril%20arginine","perindopril%20erbumine"],"PubChem":["144206638","170464836","56463760"],"Wikipedia":["Perindopril"],"drugbank":["DB00790"],"chEBI":["8024"]},"childChemblIds":["CHEMBL3544986","CHEMBL1200343"],"count":11,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003095","EFO_0001645","EFO_0000401","EFO_0000249","EFO_0000319","EFO_0001358","Orphanet_558","EFO_0000537","EFO_1001480","EFO_1000654","MONDO_0002491","EFO_0003144","EFO_0003884","EFO_1002032","EFO_0000612","EFO_0004701","EFO_0001360","EFO_0000407"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for cardiovascular disease and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1615209","canonicalSmiles":"COCCCOc1ccnc(C[S@@+]([O-])c2nc3ccccc3[nH]2)c1C","inchiKey":"YREYEVIYCVEVJK-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXRABEPRAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexrabeprazole"],"crossReferences":{"drugbank":["DB13762"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1615439","canonicalSmiles":"C[C@H]1[C@H](c2ccccc2)OCCN1C","inchiKey":"MFOCDFTXLCYLKU-CMPLNLGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENDIMETRAZINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-169187","Phendimetrazine"],"crossReferences":{"DailyMed":["phendimetrazine%20tartrate"],"drugbank":["DB01579"],"chEBI":["8059"]},"childChemblIds":["CHEMBL2062163"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0010445"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1615775","canonicalSmiles":"O=P(O)(O)C(O)P(=O)(O)O","inchiKey":"HJZKOAYDRQLPME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXIDRONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HMDP","Oxidronic acid"],"crossReferences":{"drugbank":["DB14159"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1643895","canonicalSmiles":"Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc21","inchiKey":"NTHPAPBPFQJABD-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMOSETRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ramosetron"],"crossReferences":{"PubChem":["50112691"],"Wikipedia":["Ramosetron"],"drugbank":["DB09290"]},"childChemblIds":["CHEMBL3181841"],"count":4,"linkedTargets":{"rows":["ENSG00000149305","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736"],"count":5},"linkedDiseases":{"rows":["MONDO_0001056","HP_0005184","EFO_0003931","EFO_0000555","EFO_0004888","EFO_0004616","HP_0002013","EFO_0006912","HP_0002018","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1652","canonicalSmiles":"CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl","inchiKey":"OMHBPUNFVFNHJK-UHFFFAOYSA-P","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBENONIUM","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ambenonium"],"crossReferences":{"PubChem":["11113478","26756578"],"Wikipedia":["Ambenonium_chloride"],"drugbank":["DB01122"],"chEBI":["2627"]},"childChemblIds":["CHEMBL1200541"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1659","canonicalSmiles":"CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"DBAKFASWICGISY-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENIRAMINE MALEATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL505","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allercalm allergy relief","Allerief","Alunex","Antagonate","Calimal","Chlor-trimeton","Chlorphenamine","Chlorpheniramine maleate","Efidac 24 chlorpheniramine maleate","Hayleve","Kloromin","Phenetron","Piriject","Piriton","Piriton allergy","Pyridamal 100","Rhino-syrup allergy","Rimarin","Teldrin"],"synonyms":["(+)-Chlorpheniramine Maleate","Chlorphenamine maleate","Chlorpheniramine Maleate","Chlorpheniramine maleate","Chlorprophenpyridamine maleate"],"crossReferences":{"DailyMed":["chlorpheniramine%20maleate"],"PubChem":["144209290","144213766","17389966","26719778","50106014","50106015","56422503"],"chEBI":["3645"]},"count":4,"approvedIndications":["EFO_0007486","HP_0012735"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0007486","HP_0012735","EFO_0000270","EFO_0003958"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for sinusitis and cough and has 2 investigational indications."}
{"id":"CHEMBL1697760","canonicalSmiles":"CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O","inchiKey":"RLWRMIYXDPXIEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MUZOLIMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," Germany"," France"],"classes":["Neurotoxicity"],"year":1987},"tradeNames":[],"synonyms":["BAY G 2821","Muzolimine"],"crossReferences":{"drugbank":["DB13801"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in European Union,  Germany and  France initially in 1987 due to Neurotoxicity."}
{"id":"CHEMBL17","canonicalSmiles":"NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1","inchiKey":"GJQPMPFPNINLKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLORPHENAMIDE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daranide","Keveyis","Oratrol"],"synonyms":["Dichlorphenamide","Diclofenamide"],"crossReferences":{"DailyMed":["dichlorphenamide"],"PubChem":["11112264","144203952","56463645"],"Wikipedia":["Diclofenamide"],"drugbank":["DB01144"],"chEBI":["101085"]},"count":4,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000167434","ENSG00000133742","ENSG00000104267","ENSG00000074410"],"count":4},"linkedDiseases":{"rows":["Orphanet_682","Orphanet_681","EFO_0000516","Orphanet_684"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and is indicated for glaucoma and has 3 investigational indications."}
{"id":"CHEMBL1742996","drugType":"Antibody","blackBoxWarning":true,"name":"BRODALUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kyntheum","Siliq"],"synonyms":["AMG 827","AMG-827","Brodalumab","KHK-4827","KHK4827"],"crossReferences":{"DailyMed":["brodalumab"],"DrugCentral":["5179"]},"count":10,"approvedIndications":["EFO_0000676","Orphanet_163927","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000177663"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_1001494","EFO_1000710","EFO_0000270","EFO_0003898","EFO_0000676","EFO_0003778","Orphanet_163927","EFO_0000540","EFO_0000717","EFO_0000384"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743031","drugType":"Antibody","blackBoxWarning":false,"name":"INDATUXIMAB RAVTANSINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BT-062","Indatuximab ravtansine"],"count":1,"linkedTargets":{"rows":["ENSG00000115884"],"count":1},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1788387","canonicalSmiles":"CCOCCN(Cc1ccc(CN(CCOCC)C(=O)C(Cl)Cl)cc1)C(=O)C(Cl)Cl","inchiKey":"MSJLJWCAEPENBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECLOZAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Falmonox"],"synonyms":["Teclozan","WIN 13,146"],"crossReferences":{"drugbank":["DB13205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL179532","canonicalSmiles":"O=C(O)c1ccc2c(C3CCCCC3)c(-c3ccccc3)n(CC(=O)N3CCOCC3)c2c1","inchiKey":"ZKEZEXYKYHYIMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL179532","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07570"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1829433","canonicalSmiles":"Cc1ccc(C(=O)N(CCCN)C(c2nc3snc(C)c3c(=O)n2Cc2ccccc2)C(C)C)cc1","inchiKey":"SMFXSYMLJDHGIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-4877","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4877","AZD4877","Azd 4877","Azd-4877"],"crossReferences":{"drugbank":["DB11671"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1908307","canonicalSmiles":"Cn1cc([S+](C)[O-])c(=O)c2ccc(F)cc21","inchiKey":"UYGONJYYUKVHDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLOSEQUINAN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"year":1993},"tradeNames":["Manoplax"],"synonyms":["BTS 49 465","Flosequinan"],"crossReferences":{"PubChem":["144206866"],"drugbank":["DB13228"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for cardiovascular disease. It was withdrawn in United Kingdom and  United States initially in 1993."}
{"id":"CHEMBL191598","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)c(COc3cccnc3)c2)[nH]n1","inchiKey":"NTMADESEDXKNFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191598","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL193482","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O","inchiKey":"PROQIPRRNZUXQM-ZXXIGWHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRIOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gynest","Ortho-gynest","Ovestin","Theelol"],"synonyms":["16.ALPHA.-HYDROXYESTRADIOL","Estriol","Estriol acetate benzoate","Estriol propionate","Estriol succinate","NSC-12169","Oestriol"],"crossReferences":{"PubChem":["11532998","144205873","144211921","170465807"],"Wikipedia":["Estriol"],"drugbank":["DB04573"],"chEBI":["27974"]},"count":6,"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_1001271","EFO_0003103","EFO_0008520","EFO_0003929","EFO_0008522","EFO_0003922","EFO_0002950"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1952329","canonicalSmiles":"CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1","inchiKey":"MHXGEROHKGDZGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SGI-1776","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGI-1776","Sgi-1776"],"crossReferences":{"PubChem":["137276030"],"drugbank":["DB12494"]},"childChemblIds":["CHEMBL1952141"],"count":3,"linkedTargets":{"rows":["ENSG00000102096","ENSG00000137193","ENSG00000198355"],"count":3},"linkedDiseases":{"rows":["EFO_0000565","EFO_0005952","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1969020","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12.O=S(=O)(O)O","inchiKey":"XGBFWQUQYQIFLB-MTTMTQIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPECTINOMYCIN SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1167","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Spectinomycin Sulfate"],"crossReferences":{"PubChem":["403967"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1976040","canonicalSmiles":"C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1","inchiKey":"BKWJAKQVGHWELA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADAVOSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD 1775","AZD-1775","AZD1775","Adavosertib","Azd-1775","MK-1775","MK1775"],"crossReferences":{"PubChem":["103905025","137276027"],"drugbank":["DB11740"]},"count":25,"linkedTargets":{"rows":["ENSG00000166483"],"count":1},"linkedDiseases":{"rows":["EFO_1000412","EFO_0001075","EFO_1001958","MONDO_0015686","MONDO_0007254","EFO_1000131","MONDO_0002087","MONDO_0044704","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000043","EFO_0006352","MONDO_0002974","MONDO_0008903","EFO_1000251","MONDO_0044710","EFO_0000330","EFO_0000707","EFO_1001963","MONDO_0002715","EFO_1000253","EFO_0000616","EFO_0000466","EFO_0000503","MONDO_0019457","MONDO_0008170","EFO_0000349","EFO_0002939","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1000238","EFO_0005537","EFO_0000702","EFO_0000574","EFO_0001378","EFO_0000519","EFO_0000181","EFO_1000494","EFO_1001960"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 25 investigational indications."}
{"id":"CHEMBL201960","canonicalSmiles":"CCCC(C(=O)c1ccc(C)cc1)N1CCCC1","inchiKey":"SWUVZKWCOBGPTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROVALERONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Misuse"],"year":1979},"tradeNames":[],"synonyms":["Pyrovalerone"],"crossReferences":{"Wikipedia":["Pyrovalerone"]},"childChemblIds":["CHEMBL2104793"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1979 due to Misuse."}
{"id":"CHEMBL2028852","canonicalSmiles":"CC(=O)O.N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O","inchiKey":"HKMZRZUEADSZDQ-DZJWSCHMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ICATIBANT ACETATE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2028850","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firazyr"],"synonyms":["HOE 140","HOE-140","Icatibant acetate"],"crossReferences":{"DailyMed":["icatibant%20acetate"]},"count":2,"approvedIndications":["Orphanet_91378"],"linkedTargets":{"rows":["ENSG00000168398"],"count":1},"linkedDiseases":{"rows":["MP_0001845","Orphanet_91378"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for hereditary angioedema and has 1 investigational indication."}
{"id":"CHEMBL2062259","canonicalSmiles":"O=C(O)C(O)C(O)C(=O)O.c1cnc2cc3c(cc2n1)C1CNCC3C1","inchiKey":"TWYFGYXQSYOKLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARENICLINE TARTRATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1396","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Champix","Chantix"],"synonyms":["CP-526,555-18","CP-526555-18","Varenicline tartrate"],"crossReferences":{"DailyMed":["varenicline%20tartrate"]},"count":3,"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","EFO_0003768","EFO_0003829"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 investigational indications."}
{"id":"CHEMBL2062267","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O=C(O)C(O)C(O)C(=O)O","inchiKey":"OJHZNMVJJKMFGX-RNWHKREASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCODONE BITARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1457","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2087337","canonicalSmiles":"CC(C)n1c(=O)c(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN(C)S(C)(=O)=O)cc2ccccc21","inchiKey":"HXLOHDZQBKCUCR-WOZUAGRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELUSETRAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TD-5108","Velusetrag"],"crossReferences":{"drugbank":["DB12702"]},"childChemblIds":["CHEMBL2105660"],"count":2,"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0000249","HP_0012450","EFO_1000948"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2096637","canonicalSmiles":"C=C/C=C\\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(\\C)C(=O)OC)C2(C)C)CC1=O.C=C/C=C\\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O","inchiKey":"VXSIXFKKSNGRRO-MXOVTSAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRETHRINS","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pyrethrins"],"crossReferences":{"DrugCentral":["4700"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL2103852","canonicalSmiles":"COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC","inchiKey":"JXONINOYTKKXQQ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROLIBULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crolibulin","EPC 2407","EPC-2407","EPC2407"],"crossReferences":{"drugbank":["DB12925"]},"count":2,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["MONDO_0002108","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103863","canonicalSmiles":"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12","inchiKey":"MAUCONCHVWBMHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABEXINOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abexinostat","CRA 024781","CRA 24781","CRA-024781","PCI 24781","PCI-24781","PZP-115891","PZP115891","S-78454","S78454"],"crossReferences":{"drugbank":["DB12565"]},"childChemblIds":["CHEMBL2105727"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2104560","canonicalSmiles":"CCOC(=O)[C@]1(c2ccccc2)CCC=C[C@H]1N(C)C","inchiKey":"WDEFBBTXULIOBB-WBVHZDCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTILIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextilidine"],"crossReferences":{"drugbank":["DB13787"],"chEBI":["77822"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104616","canonicalSmiles":"CCN(CC)CCn1c(Cc2ccc(Cl)cc2)nc2cc([N+](=O)[O-])ccc21","inchiKey":"GPZLDQAEBHTMPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLONITAZENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clobedolum","Clonitazene"],"crossReferences":{"drugbank":["DB01523"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105024","canonicalSmiles":"CNC(=O)CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I","inchiKey":"HHFIATHHSBFCBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOGLICIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ioglicic acid","SH H 200 AB"],"crossReferences":{"drugbank":["DB13701"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105648","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21","inchiKey":"YTFHCXIPDIHOIA-DHZHZOJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALOVAROTENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CLM-001","Palovarotene","R-667","RG-667","RO-3300074","RO3300074"],"crossReferences":{"drugbank":["DB12320"]},"count":1,"linkedTargets":{"rows":["ENSG00000172819"],"count":1},"linkedDiseases":{"rows":["Orphanet_337"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105691","canonicalSmiles":"CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1.Cl","inchiKey":"YGRHOYQMBLLGEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIDOPIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL596802","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACR16 HYDROCHLORIDE","ASP2314 HYDROCHLORIDE","FR310826","Pridopidine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105746","canonicalSmiles":"Cl.NC(=O)c1ccc(Oc2ccc(CNCCC3CCOCC3)cc2F)nc1","inchiKey":"UQHILNMISZVWIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODELEPRAN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103878","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2196044 HCL","Odelepran hydrochloride","Ondelopran hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105987","canonicalSmiles":"CC1=CC(=O)C=C2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3[C@@]12C","inchiKey":"PEPMWUSGRKINHX-TXTPUJOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATAMESTANE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atamestane","SH-489"],"crossReferences":{"drugbank":["DB12194"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106571","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=C(Cl)C(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"KCZCIYZKSLLNNH-FBPKJDBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOSTEBOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clostebol","Clostebol acetate"],"crossReferences":{"PubChem":["144205410"],"drugbank":["DB01521"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106999","canonicalSmiles":"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC3=CCCC3)CC[C@@H]12","inchiKey":"IUVKMZGDUIUOCP-BTNSXGMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINBOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinbolone"],"crossReferences":{"drugbank":["DB13484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107143","canonicalSmiles":"O=P(NCCCl)(NCCCl)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"PSVUJBVBCOISSP-SPFKKGSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUFOSFAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D 19575","D-19575","Glufosfamide"],"crossReferences":{"drugbank":["DB06177"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2107725","canonicalSmiles":"Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)N4CCC[C@H]4C(=O)NCCCNC(=O)c4ccc(C(=N)N)cc4)c3Cl)c2n1","inchiKey":"XUHBBTKJWIBQMY-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANATIBANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anatibant","Lf16-0687","XY2405"],"crossReferences":{"drugbank":["DB05038"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108222","drugType":"Unknown","blackBoxWarning":false,"name":"ALOXIPRIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Palaprin fte"],"synonyms":["Aloxiprin"],"crossReferences":{"DrugCentral":["4760"]},"count":3,"approvedIndications":["HP_0001945","HP_0004419","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0001945","HP_0004419","EFO_0003843"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
{"id":"CHEMBL2108340","drugType":"Protein","blackBoxWarning":false,"name":"TRIDECACTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tridecactide"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108525","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYFEROSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Jefron"],"synonyms":["Iron carbohydrate complex","Polyferose"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108669","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 TACATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Afp-cide"],"synonyms":["HAFP-31","Yttrium (90y) tacatuzumab tetraxetan","Yttrium y 90 tacatuzumab tetraxetan"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108684","drugType":"Unknown","blackBoxWarning":false,"name":"NELIPEPIMUT-S","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["E75 peptide"],"synonyms":["E-75 PEPTIDE","E75 PEPTIDE","Nelipepimut s","Nelipepimut-s"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108700","drugType":"Enzyme","blackBoxWarning":false,"name":"GLUCOSE OXIDASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COMPONENT OF E-101","E.C. 1.1.3.4","GO","GO; COMPONENT OF E-101","Glucose oxidase"],"count":2,"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108767","drugType":"Antibody","blackBoxWarning":false,"name":"RUPLIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Antova"],"synonyms":["BG-9588","BG9588","HU-5C8","Ruplizumab","hu5c8"],"count":1,"linkedTargets":{"rows":["ENSG00000102245"],"count":1},"linkedDiseases":{"rows":["EFO_0005761"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109042","drugType":"Unknown","blackBoxWarning":false,"name":"INFLUENZA VIRUS VACCINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluogen","Flushield","Fluzone"],"synonyms":["Influenza virus vaccine","Influenza, live attenuated"],"count":21,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 21 investigational indications."}
{"id":"CHEMBL2109413","drugType":"Antibody","blackBoxWarning":false,"name":"AS-1409","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1409","As-1409","HUBC1-HUIL12"],"count":2,"linkedTargets":{"rows":["ENSG00000115414"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","EFO_0000681"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109435","drugType":"Antibody","blackBoxWarning":false,"name":"HUA33","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUA33","Hua33"],"count":2,"linkedTargets":{"rows":["ENSG00000143167"],"count":1},"linkedDiseases":{"rows":["EFO_0004142","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110756","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)C(=O)[C@]1(C)OC","inchiKey":"BELMMAAWNYFCGF-PZXAHSFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITEMCINAL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mitemcinal"],"crossReferences":{"drugbank":["DB06587"]},"childChemblIds":["CHEMBL2105890"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2111029","canonicalSmiles":"N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O","inchiKey":"LLEUXCDZPQOJMY-AAEUAGOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OGLUFANIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-334073","Oglufanide"],"crossReferences":{"drugbank":["DB05779"],"chEBI":["73512"]},"childChemblIds":["CHEMBL2107123"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL213907","canonicalSmiles":"COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1[C@@H](NC(C)=O)CC2","inchiKey":"LEQAKWQJCITZNK-AXHKHJLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL213907","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204021"],"drugbank":["DB11582"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146063","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12.Cl","inchiKey":"CBHYYLPALVVVEY-MRFRVZCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORTETRACYCLINE HYDROCHLORIDE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL404520","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aureomicina","Aureomycin","Chlortet hcl","Fermycin","Isaphamycin"],"synonyms":["Chlortetracycline hydrochloride"],"crossReferences":{"PubChem":["144203904","144212027"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950."}
{"id":"CHEMBL2165191","canonicalSmiles":"Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1","inchiKey":"IRTDIKMSKMREGO-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-6482","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-6482","AZD6482","Azd 6482","Azd-6482"],"crossReferences":{"drugbank":["DB14980"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219416","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5.O=C(O)C(=O)O","inchiKey":"MNYIRXLCPODKLG-VUTNLTPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALOXEGOL OXALATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2219418","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Movantik"],"synonyms":["AZ13337019 oxalate","NKTR-118 oxalate","Naloxegol oxalate"],"crossReferences":{"DailyMed":["naloxegol%20oxalate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014."}
{"id":"CHEMBL223643","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O","inchiKey":"FCFNRCROJUBPLU-DNDCDFAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALINOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valino","Valinomycin"],"crossReferences":{"drugbank":["DB14057"],"chEBI":["28545"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2336071","canonicalSmiles":"CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1","inchiKey":"KIHYPELVXPAIDH-HNSNBQBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIPONIMOD","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BAF-312","BAF312","Baf312","NVP-BAF312-NX","Siponimod"],"crossReferences":{"DailyMed":["siponimod%20fumaric%20acid"],"drugbank":["DB12371"]},"childChemblIds":["CHEMBL4298150"],"count":8,"approvedIndications":["EFO_0000540"],"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003086","EFO_0003840","EFO_0000398","EFO_0001421","EFO_0003929","EFO_0003063","EFO_0000540","EFO_0008522"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for immune system disease and has 7 investigational indications."}
{"id":"CHEMBL2348780","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"ZYTXTXAMMDTYDQ-DGEXFFLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2348780","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL235157","canonicalSmiles":"COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC","inchiKey":"NVINUNQBDNEMSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL235157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905635"],"drugbank":["DB06932"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2358886","canonicalSmiles":"COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC.Cl.Cl.Cl","inchiKey":"ZNJRHEVYOYMEHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2358886","maximumClinicalTrialPhase":0,"parentId":"CHEMBL119","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205548","170465176"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2369989","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)[N+](C)(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O","inchiKey":"DUQRILZXKXSRIY-RUBJUKRASA-N","drugType":"Protein","blackBoxWarning":false,"name":"ATILMOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atilmotin","BAX-ACC-1638","MOT-288","OHM-11638"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL241577","canonicalSmiles":"O=C(O)COc1cc(Cl)ccc1C(=O)NCc1cccc([N+](=O)[O-])c1","inchiKey":"VABIMMIJVWNHFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL241577","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07030"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL243716","canonicalSmiles":"COc1nc(N)nc2c1ncn2[C@H]1CC[C@@H](CO)O1","inchiKey":"FJAOCNGVPLTSLD-NKWVEPMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METACAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metacavir"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL253592","canonicalSmiles":"CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1","inchiKey":"RYOOHIUJEJZCFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMYLOFIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acamylophenine","Acamylophenine hydrochloride","Camylofin"],"crossReferences":{"PubChem":["144205710","170465936","26757945"],"drugbank":["DB13738"]},"childChemblIds":["CHEMBL4303602"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL257036","canonicalSmiles":"NCc1ccccc1-c1ccccc1","inchiKey":"YHXKXVFQHWJYOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Phenylbenzylamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Phenylbenzylamine"],"crossReferences":{"drugbank":["DB07412"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257626","canonicalSmiles":"C[C@@](N)(C(=O)O)c1ccc(C(=O)O)cc1","inchiKey":"DNCAZYRLRMTVSF-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257626","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111462","11113453","11113454","26751683"],"drugbank":["DB04256"],"chEBI":["43876"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL26570","canonicalSmiles":"Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.[Na+]","inchiKey":"GXOMMGAFBINOJY-SLINCCQESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL26570","maximumClinicalTrialPhase":0,"parentId":"CHEMBL893","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50085964"],"chEBI":["34691"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL283807","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"RQFCJASXJCIDSX-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL283807","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01972"],"chEBI":["17345"]},"childChemblIds":["CHEMBL1627076"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284838","canonicalSmiles":"O=C(NCCCOc1ccc2[nH]c(=O)ccc2c1)N(C1CC1)[C@@H]1CCCC[C@H]1O","inchiKey":"ULGNGSQNNMKROG-WOJBJXKFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"K-134","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K-134","OPC-33509"],"crossReferences":{"drugbank":["DB12685"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL288149","canonicalSmiles":"CC(=O)NC[C@H]1CN(c2ccc(N3CCSCC3)c(F)c2)C(=O)O1","inchiKey":"FNDDDNOJWPQCBZ-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUTEZOLID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-100480","Sutezolid","U 100480","U-100480"],"crossReferences":{"drugbank":["DB11905"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL291278","canonicalSmiles":"CN[C@H](CC(=O)O)C(=O)O","inchiKey":"HOKKHZGPKSLGJE-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-METHYL-D-ASPARTIC ACID (NMDA)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-2-(Methylamino)Succinic Acid","2-Methylamino-Succinic Acid","N-Methyl-Daspartate","N-methyl-d-aspartic acid (nmda)","Nmda"],"crossReferences":{"PubChem":["11111449","11113384","26751633","46500421","50104312","50104313","50104314","90341063"],"Wikipedia":["N-Methyl-D-aspartic_acid"],"chEBI":["31882"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL293212","canonicalSmiles":"N=C(Nc1ccc(CCNCc2cccc(Cl)c2)cc1)c1cccs1","inchiKey":"ZZVGLDBDDYESAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL293212","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03449"]},"childChemblIds":["CHEMBL3216853"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30116","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCNCC3)nc21","inchiKey":"JOHZPMXAZQZXHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPEMIDIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pipram"],"synonyms":["Pipemidic acid","Pipemidic acid trihydrate"],"crossReferences":{"PubChem":["11112780","144204206","170465767","855987"],"Wikipedia":["Pipemidic_acid"],"drugbank":["DB13823"],"chEBI":["75250"]},"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL303933","canonicalSmiles":"Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1","inchiKey":"UCRHFBCYFMIWHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAQUINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piperaquine"],"crossReferences":{"Wikipedia":["Piperaquine"],"drugbank":["DB13941"]},"childChemblIds":["CHEMBL539666","CHEMBL1652442"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3039522","canonicalSmiles":"CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12","inchiKey":"PKWRMUKBEYJEIX-DXXQBUJASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIRINAPANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Birinapant","TL-32711","TL32711"],"crossReferences":{"drugbank":["DB11782"]},"count":10,"linkedTargets":{"rows":["ENSG00000110330","ENSG00000023445"],"count":2},"linkedDiseases":{"rows":["EFO_1000253","EFO_0000616","EFO_0000198","EFO_1001958","MONDO_0015686","MONDO_0008170","EFO_0000222","EFO_0004197","EFO_0000311","MONDO_0002158","EFO_1001100","EFO_1000251","EFO_0000181","EFO_1000494"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3092041","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"LGGDXXJAGWBUSL-BKRJIHRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLDIHYDROCODEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetyldihydrocodeine"],"crossReferences":{"drugbank":["DB01538"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3125455","canonicalSmiles":"[2H]C([2H])(c1ccc(OCC)cc1)c1cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)ccc1Cl","inchiKey":"JVHXJTBJCFBINQ-UUFJFONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3125455","maximumClinicalTrialPhase":0,"parentId":"CHEMBL429910","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137353","drugType":"Antibody","blackBoxWarning":false,"name":"BIMAGRUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BYM-338","BYM338","Bimagrumab"],"count":6,"linkedTargets":{"rows":["ENSG00000114739"],"count":1},"linkedDiseases":{"rows":["EFO_1000653","EFO_0009851","EFO_0007323","HP_0004326","EFO_0000341","EFO_0001360"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3142541","canonicalSmiles":"CCCCOC(=O)c1ccc(N)cc1.CCCCOC(=O)c1ccc(N)cc1.O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1","inchiKey":"ATAGSVCDFKGYPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAMBEN PICRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL127516","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"," Psychiatric toxicity"],"year":1964},"tradeNames":[],"synonyms":["ABBOTT-34842","Butamben picrate"],"crossReferences":{"chEBI":["86300"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1964 due to Dermatological toxicity and  Psychiatric toxicity."}
{"id":"CHEMBL3143955","canonicalSmiles":"CCCN[C@H]1CCc2nc(N)sc2C1.Cl.Cl","inchiKey":"QMNWXHSYPXQFSK-KLXURFKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3143955","maximumClinicalTrialPhase":0,"parentId":"CHEMBL301265","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"chEBI":["51148"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3286830","canonicalSmiles":"C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21","inchiKey":"IIXWYSCJSQVBQM-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORLATINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lorbrena"],"synonyms":["Lorlatinib","PF-06463922"],"crossReferences":{"DailyMed":["lorlatinib"],"drugbank":["DB12130"]},"childChemblIds":["CHEMBL4539157"],"count":6,"approvedIndications":["EFO_0000616","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000171094","ENSG00000143924"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","EFO_0003032","EFO_0003060","EFO_0000621","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL3301587","drugType":"Antibody","blackBoxWarning":false,"name":"DURVALUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imfinzi"],"synonyms":["Durvalumab","MEDI-4736","MEDI4736"],"crossReferences":{"DailyMed":["durvalumab"]},"count":83,"approvedIndications":["EFO_0000294","EFO_0000616","EFO_0000292","EFO_0008528","EFO_0003060","EFO_0000311","MONDO_0001187"],"linkedTargets":{"rows":["ENSG00000120217"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003891","EFO_0000365","EFO_0001075","MONDO_0003890","EFO_0000756","EFO_0000681","EFO_0000571","EFO_1000657","EFO_0005952","EFO_0000228","MONDO_0044704","EFO_1001951","MONDO_0001416","MONDO_0003059","EFO_0000588","EFO_0009709","MONDO_0002974","MONDO_0008903","EFO_0000182","EFO_0000501","EFO_0008528","MONDO_0003199","EFO_0000641","EFO_1000251","EFO_0000514","MONDO_0003001","MONDO_0021115","EFO_0000198","EFO_0002618","EFO_1001931","EFO_0005922","EFO_0001642","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0005842","EFO_1001968","EFO_0002429","MONDO_0008315","EFO_0005221","EFO_0000294","EFO_0003868","EFO_0005537","EFO_0004284","EFO_0000574","EFO_0006544","EFO_0001378","EFO_0000348","MONDO_0044903","EFO_0000292","MONDO_0021117","MONDO_0044887","EFO_0002913","MONDO_0007254","EFO_0004230","EFO_1001012","EFO_0000708","EFO_0001071","EFO_0000305","MONDO_0020654","MONDO_0001187","EFO_0002430","MONDO_0001056","EFO_1001480","EFO_1000044","EFO_0003968","EFO_0000770","EFO_0000673","EFO_0000707","EFO_0000616","EFO_0005220","MONDO_0021656","EFO_0006859","EFO_0000503","EFO_0000478","EFO_0000403","MONDO_0003002","MONDO_0007576","EFO_0000313","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0006738","EFO_1001961","EFO_0003863","EFO_0000095","EFO_0002517","EFO_0000702","EFO_0000199","MONDO_0018906","EFO_0003050","EFO_0000691","EFO_0000181","EFO_0000519","MONDO_0024880"],"count":96},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 7 approved and 76 investigational indications."}
{"id":"CHEMBL3301592","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM ZIRCONIUM CYCLOSILICATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lokelma"],"synonyms":["Sodium zirconium cyclosilicate","UXSi-9","ZS","ZS-9"],"crossReferences":{"DailyMed":["sodium%20zirconium%20cyclosilicate"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and has 1 investigational indication."}
{"id":"CHEMBL3306201","canonicalSmiles":"CN(C)C=Nc1c(I)cc(I)c(CCC(=O)O)c1I","inchiKey":"YQNFBOJPTAXAKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3306201","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09333"]},"childChemblIds":["CHEMBL3184539"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3355009","canonicalSmiles":"CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1","inchiKey":"IDXKJSSOUXWLDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-3179106","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-3179106","Gsk-3179106","Gsk3179106"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL338802","canonicalSmiles":"NC(N)=NS(=O)(=O)c1ccc(N)cc1","inchiKey":"BRBKOPJOKNSWSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAGUANIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gppe susp fte","Guanimycin"],"synonyms":["Sulfaguanidine","Sulphaguanidine"],"crossReferences":{"PubChem":["11112136","144203880","170465708","856017"],"drugbank":["DB13726"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL34412","canonicalSmiles":"Nc1nc2c(c(=O)[nH]1)C[C@@H](CCc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2","inchiKey":"ZUQBAQVRAURMCL-DOMZBBRYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMETREXOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY264618","Lometrexol"],"crossReferences":{"drugbank":["DB12769"]},"childChemblIds":["CHEMBL2104666"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL351769","canonicalSmiles":"Nc1ccc([As](=O)(O)O)cc1","inchiKey":"XKNKHVGWJDPIRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARSANILIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arsanilic acid"],"crossReferences":{"PubChem":["144204755","144211760","170465635","26753349","26753350","29215145","56422181","68723","8139922"],"Wikipedia":["Arsanilic_acid"],"drugbank":["DB03006"],"chEBI":["49477"]},"childChemblIds":["CHEMBL3188525"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544958","drugType":"Small molecule","blackBoxWarning":false,"name":"CER-002","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cer-002"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544998","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-3007113","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly-3007113"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["MONDO_0024880"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545001","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-8353","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-8353","SCH-900353"],"count":2,"linkedTargets":{"rows":["ENSG00000102882","ENSG00000100030"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001951"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545039","canonicalSmiles":"Cc1cc(Cl)cc2c1N(Cc1cccc(C(F)(F)F)c1)C(=O)C21NC(=O)NC1=O","inchiKey":"DXDVSYALLVVBOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD1386","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD1386","Azd 1386","Azd1386"],"count":3,"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","HP_0012532","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545064","canonicalSmiles":"CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O.CS(=O)(=O)O","inchiKey":"OXYYOEIGQRXGPI-WSZWBAFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALABOSTAT MESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL67279","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PT-100","Talabostat mesylate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545097","canonicalSmiles":"CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21","inchiKey":"GYLDXIAOMVERTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPANISERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INK-128","INK128","Ink-128","MLN-0128","MLN0128","Mln-0128","Sapanisertib","TAK-228"],"crossReferences":{"drugbank":["DB11836"]},"childChemblIds":["CHEMBL3943182"],"count":24,"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0007416","MONDO_0015686","EFO_0000681","EFO_1000231","MONDO_0007254","EFO_1001465","MONDO_0004222","EFO_0004230","EFO_0000209","EFO_0000708","MONDO_0003541","EFO_1000043","EFO_0000182","EFO_1000251","EFO_1001963","EFO_1000045","EFO_0009441","EFO_0000616","EFO_0000466","MONDO_0002108","EFO_1001968","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_1001471","EFO_1000238","EFO_0000574","EFO_0006544","EFO_0001378","EFO_0000519"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL3545125","canonicalSmiles":"CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O","inchiKey":"FTBQORVNHOIASH-CKYFFXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIROGABALIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-200-0700","A200-0700","Mirogabalin"],"crossReferences":{"drugbank":["DB11825"]},"childChemblIds":["CHEMBL3545257"],"count":3,"linkedTargets":{"rows":["ENSG00000007402","ENSG00000153956"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_1000783","EFO_0005687","EFO_0006510"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545235","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CC2)C2(C1)OCCO2","inchiKey":"OXWUWXCJDBRCCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sim-6802","Simotinib"],"count":1,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL36255","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)c(O)c1O","inchiKey":"YUSYSJSHVJULID-WAYWQWQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COMBRETASTATIN A-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Combretastatin a-1","Combretastatin a1","NSC-600032","OXI4500"],"crossReferences":{"PubChem":["483048"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL367788","canonicalSmiles":"O=C(NO)c1ccc(O)c(O)c1","inchiKey":"QJMCKEPOKRERLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSC-324360","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-324360"],"crossReferences":{"PubChem":["457824"],"drugbank":["DB12948"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707293","drugType":"Small molecule","blackBoxWarning":false,"name":"XEN-D0501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xen-d0501"],"count":3,"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["HP_0012735","EFO_0000341","EFO_0001360"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707303","canonicalSmiles":"O=C([O-])[C@@H]1CCC(O)=N1.O=C([O-])[C@@H]1CCC(O)=N1.[Mg+2]","inchiKey":"JQAACYUZYRBHGG-QHTZZOMLSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM PIDOLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL397976","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium pidolate"],"crossReferences":{"DrugCentral":["4597"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707341","canonicalSmiles":"CBr.CN(C)CCOC(c1ccccc1)c1ccccc1","inchiKey":"RSABECAAVLQBOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENHYDRAMINE METHYLBROMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diphenhydramine methylbromide"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707447","canonicalSmiles":"CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].[Ca+2]","inchiKey":"JWLAOERSRUNGEF-JQVJEGKNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM PANGAMATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707449","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium pangamate"],"crossReferences":{"DrugCentral":["4385"],"drugbank":["DB13590"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3780934","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1.O=C(O)C(F)(F)F","inchiKey":"FXDCVRWMRQEVTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3780934","maximumClinicalTrialPhase":0,"parentId":"CHEMBL437","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3818130","canonicalSmiles":"CC(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O","inchiKey":"FQVLRGLGWNWPSS-BXBUPLCLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ADH-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adh-1"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833303","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS GLUCONATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3991443","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fergon","Sideromal"],"synonyms":["E-579","Ferrous gluconate","Ferrous gluconate dihydrate","INS NO.579","INS-579"],"crossReferences":{"DrugCentral":["4491"]},"count":1,"approvedIndications":["EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL3833336","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)[O-].CC(C)(Oc1ccc(Cl)cc1)C(=O)[O-].[Al+3].[OH-]","inchiKey":"USWVMPGQVYZHCA-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM CLOFIBRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL683","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aluminium clofibrate","Aluminum clofibrate"],"crossReferences":{"DrugCentral":["4437"],"drugbank":["DB13780"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833386","drugType":"Cell","blackBoxWarning":false,"name":"GALINPEPIMUT-S","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Galinpepimut-s","SLS-001"],"count":1,"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL392149","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"OESBDSFYJMDRJY-BAYCTPFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECADENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVT-510","Tecadenoson"],"crossReferences":{"drugbank":["DB04954"]},"count":1,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3924132","canonicalSmiles":"CCOc1cc(-c2nncn2C)ccc1Nc1ncc2cc(C)nc(NCC(C)(C)C)c2n1","inchiKey":"SGWLRDAOCLITOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3924132","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15498"]},"childChemblIds":["CHEMBL4242594"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL39560","canonicalSmiles":"CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2","inchiKey":"NOSIYYJFMPDDSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEPROMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acepromazine","Acezine 2","Atravet"],"crossReferences":{"PubChem":["11112541"],"Wikipedia":["Acepromazine"],"drugbank":["DB01614"],"chEBI":["44932"]},"childChemblIds":["CHEMBL1883146"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989515","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.O.O.O.O.c1ccc(CNCCNCc2ccccc2)cc1","inchiKey":"WIDKTXGNSOORHA-CJHXQPGBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENICILLIN G BENZATHINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicillin","Bicillin l-a","Bicillin l-a tubex","Extencilline","Penadur 6-3-3","Penidural","Penidural la","Permapen","Retarpen"],"synonyms":["Benzathine benzylpenicillin","Benzathine penicillin","Benzethacil","Benzylpenicillin benzathine","Benzylpenicillin benzathine hydrate","Penicillin g benzathine"],"crossReferences":{"DailyMed":["penicillin%20g%20benzathine"]},"count":6,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for bacterial disease and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989716","canonicalSmiles":"CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.O.O=S(=O)(O)c1ccc2ccccc2c1","inchiKey":"GBKONKCASNNUQD-VGHSCWAPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPOXYPHENE NAPSYLATE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1213351","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2014},"tradeNames":["Darvon-n"],"synonyms":["Dextropropoxyphene napsilate","Propoxyphene napsylate","Propoxyphene napsylate cii","Propoxyphene napsylate monohydrate"],"crossReferences":{"DailyMed":["propoxyphene%20napsylate"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1971 and is indicated for pain. It was withdrawn in United States  in 2014 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL404108","canonicalSmiles":"Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1","inchiKey":"KHPKQFYUPIUARC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMIRACOXIB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Hepatotoxicity"],"year":2007},"tradeNames":["Prexige"],"synonyms":["COX-189","Lumiracoxib"],"crossReferences":{"PubChem":["144207115","170465597"],"Wikipedia":["Lumiracoxib"],"drugbank":["DB01283"],"chEBI":["73044"]},"count":5,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002506","EFO_1000786","EFO_0004274","EFO_0004616","EFO_0003843","EFO_0005755"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 4 investigational indications. It was withdrawn in European Union  in 2007 due to Hepatotoxicity."}
{"id":"CHEMBL417016","canonicalSmiles":"OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"GUBGYTABKSRVRQ-DCSYEGIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTOSE, ANHYDROUS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anhydrous lactose","Lactose","Lactose anhydrous","Lactose, anhydrous"],"crossReferences":{"PubChem":["144212183"],"Wikipedia":["Lactose"],"chEBI":["36218"]},"childChemblIds":["CHEMBL2106323"],"count":21,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 21 investigational indications."}
{"id":"CHEMBL42126","canonicalSmiles":"COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1","inchiKey":"RRRUXBQSQLKHEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICLAMILAST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piclamilast","RP 73401","RP-73041","RP-73401"],"crossReferences":{"Wikipedia":["Piclamilast"],"drugbank":["DB01791"],"chEBI":["47619"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL426560","canonicalSmiles":"O=C(O)CNC(=O)c1nc(Cl)c2ccccc2c1O","inchiKey":"OUQVKRKGTAUJQA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL426560","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08687"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428495","canonicalSmiles":"O=C(O)Cc1cccc2ccccc12","inchiKey":"PRPINYUDVPFIRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Naphthalen-1-ylacetic acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naphthalen-1-ylacetic acid"],"crossReferences":{"PubChem":["144204602","144213968","170466030","17389810","26752862","49825821"],"Wikipedia":["1-Naphthaleneacetic_acid"],"drugbank":["DB01750"],"chEBI":["32918"]},"childChemblIds":["CHEMBL3559962"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297107","canonicalSmiles":"CC(C)N1CC(O)C2=CC(=NNC(N)=O)C(=O)C=C21","inchiKey":"XZKVIDLLLOUTSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRAZOCHROME","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iprazochrome"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297225","canonicalSmiles":"CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2nc(C#N)c[nH]2)CC1.Cl","inchiKey":"GDFIUUZLRLJTSJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDICOTINIB HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3674570","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edicotinib hydrochloride","JNJ-40346527 HCI"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297618","canonicalSmiles":"CCOC(=O)C(COC(=O)Cc1ccc(NC(=O)c2ccccc2-c2ccc(C(F)(F)F)cc2)c(C(=O)N(C)C)c1)(C(=O)OCC)c1ccccc1","inchiKey":"FPUQGCOBYOXAED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRANOTAPIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Granotapide","JTT-130","Jtt-130"],"crossReferences":{"drugbank":["DB12934"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297685","drugType":"Unknown","blackBoxWarning":false,"name":"ABT-925","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-925"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297700","drugType":"Antibody","blackBoxWarning":false,"name":"BIMEKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bimekizumab","UCB-4940","UCB4940","Ucb4940"],"count":5,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298004","drugType":"Antibody","blackBoxWarning":false,"name":"VOPRATELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JTX-2011","Jtx 2011","Jtx-2011","Vopratelimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298030","drugType":"Protein","blackBoxWarning":false,"name":"EFGIVANERMIN ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efgivanermin alfa","MEDI-1873","MEDI1873","Medi 1873","Medi1873"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4303307","canonicalSmiles":"Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1","inchiKey":"PVWVKJZCXALBAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303307","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201303","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL433501","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3ccccc3O)nc2c1","inchiKey":"URJKRCBBKTXOHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL433501","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL434394","canonicalSmiles":"OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1","inchiKey":"KOHIRBRYDXPAMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBIVOLOL","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hypoloc","Nebilet"],"synonyms":["Nebivolol","R-65824","R65,824"],"crossReferences":{"DailyMed":["nebivolol%20hydrochloride"],"Wikipedia":["Nebivolol"],"drugbank":["DB04861"],"chEBI":["64019"]},"childChemblIds":["CHEMBL1201731"],"count":6,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0008527","EFO_0004234","EFO_0001645","EFO_0000319","Orphanet_558","EFO_0003882","EFO_0000537","EFO_0003914","EFO_0000195","EFO_0008585","EFO_0003144","EFO_0000712","EFO_1002032","EFO_0008583","EFO_0004225","EFO_0008586"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for cardiovascular disease and has 5 investigational indications."}
{"id":"CHEMBL445353","canonicalSmiles":"C=CCN(C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)coc2c1","inchiKey":"JYNZIOFUHBJABQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445353","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02339"]},"childChemblIds":["CHEMBL114740"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL449317","canonicalSmiles":"COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O","inchiKey":"QUQPHWDTPGMPEX-QJBIFVCTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HESPERIDIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hesperidin","NSC-31048"],"crossReferences":{"PubChem":["144203999","50086731"],"Wikipedia":["Hesperidin"],"drugbank":["DB04703"],"chEBI":["28775"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL455477","canonicalSmiles":"C=CC1=C(C)/C(=C/C2=N/C(=C\\c3[nH]c(/C=C4\\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)C(CCC(=O)O)=C2C)NC1=O","inchiKey":"QBUVFDKTZJNUPP-BBROENKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BILIVERDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biliverdin"],"crossReferences":{"Wikipedia":["Biliverdin"],"drugbank":["DB02073"],"chEBI":["17033"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL458876","canonicalSmiles":"Nc1nc(N)c2ncn([C@H]3CO[C@@H](CO)O3)c2n1","inchiKey":"RLAHNGKRJJEIJL-RFZPGFLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMDOXOVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-DAPD","Amdoxovir","DAPD"],"crossReferences":{"Wikipedia":["Amdoxovir"],"drugbank":["DB06619"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594257","canonicalSmiles":"CCOC(=O)[C@H](C)N[P@](=O)(CO[C@@H]1C=C(F)[C@H](n2cnc3c(N)ncnc32)O1)Oc1ccccc1","inchiKey":"OCJRRXHWPBXZSU-BNCZGPJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROVAFOVIR ETALAFENAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9131","GS-9148 PHOSPHONOAMIDATE PRODRUG","GS9131","Gs-9131","Rovafovir etalafenamide"],"childChemblIds":["CHEMBL4594289"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL482967","canonicalSmiles":"Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1","inchiKey":"GPSZYOIFQZPWEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYC-116","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYC-116","Cyc 116","Cyc-116"],"crossReferences":{"PubChem":["103904403","137276048"]},"count":1,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000178999","ENSG00000105146"],"count":4},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL485629","canonicalSmiles":"O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O","inchiKey":"JJWKQXNHYDJXKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0873","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0873","MK0873","Mk-0873"],"crossReferences":{"drugbank":["DB13029"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL487739","canonicalSmiles":"COc1ccc(CCc2c3nc[nH]c3cc3c(=O)[nH]c(N)nc23)cc1","inchiKey":"UKRVQKUVWNDGMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL487739","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL504567","canonicalSmiles":"O=c1ncccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"RPQZTTQVRYEKCR-WCTZXXKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZEBULARINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zebularine"],"crossReferences":{"drugbank":["DB03068"],"chEBI":["46938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL521686","canonicalSmiles":"O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1","inchiKey":"FDLYAMZZIXQODN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLAPARIB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lynparza"],"synonyms":["AZ-2281","AZ2281","AZD-2281","AZD2281","KEYLYNK-010 COMPONENT OLAPARIB","KU-0059436","KU-59436","OLAPARIB COMPONENT OF KEYLYNK-010","Olaparib"],"crossReferences":{"DailyMed":["olaparib"],"PubChem":["124947876","164339421","174007124"],"Wikipedia":["Olaparib"],"drugbank":["DB09074"],"chEBI":["83766"]},"count":53,"approvedIndications":["Orphanet_398934","EFO_0000616","EFO_0003893","EFO_0001075","MONDO_0008170","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484","ENSG00000041880"],"count":3},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003869","EFO_0001361","EFO_0000637","EFO_0001075","EFO_1001958","EFO_0000681","EFO_1000984","EFO_1001951","MONDO_0003059","EFO_0000588","MONDO_0002974","EFO_1000251","EFO_0002918","EFO_0000514","MONDO_0002715","EFO_0002618","Orphanet_145","EFO_0003893","MONDO_0008170","EFO_1001512","EFO_1001968","MONDO_0008315","EFO_0005221","EFO_0001663","EFO_0009708","EFO_0000294","Orphanet_398934","MONDO_0015917","EFO_0001061","EFO_1001100","EFO_1000238","EFO_0000574","EFO_0006544","EFO_1001901","MONDO_0015686","MONDO_0007254","EFO_0004230","MONDO_0002087","EFO_0000305","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0003968","EFO_0003860","EFO_1001974","EFO_0000673","EFO_0000196","EFO_0000707","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0006859","EFO_0000503","EFO_0000313","EFO_0003060","EFO_0000311","EFO_0000174","EFO_0002517","MONDO_0011962","EFO_0000702","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0000519"],"count":67},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 6 approved and 47 investigational indications."}
{"id":"CHEMBL539770","canonicalSmiles":"CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C.Cl","inchiKey":"RNGHAJVBYQPLAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERODILINE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL363295","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"," Spain"," United Kingdom"],"classes":["Cardiotoxicity"],"year":1991},"tradeNames":["Micturin 12.5","Micturin 25"],"synonyms":["Terodiline hydrochloride"],"crossReferences":{"PubChem":["144206962"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986. It was withdrawn in Germany,  Spain and  United Kingdom initially in 1991 due to Cardiotoxicity."}
{"id":"CHEMBL564912","canonicalSmiles":"O=C1CCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl","inchiKey":"VXIYTVJEIXMAQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL564912","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01948"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL57242","canonicalSmiles":"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(O)n2)cc1","inchiKey":"KGSXMPPBFPAXLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZILSARTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azilsartan","TAK-536"],"crossReferences":{"chEBI":["68850"]},"count":4,"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_1002032","EFO_0001360","EFO_0000400","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL58910","canonicalSmiles":"O=C(O)[C@@H](O)c1ccccc1","inchiKey":"IWYDHOAUDWTVEP-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Hydroxy-Phenyl-Acetic Acid Anion","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxy-Phenyl-Acetic Acid Anion"],"crossReferences":{"PubChem":["11532933","26513820"],"drugbank":["DB03357"],"chEBI":["32800"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL589586","canonicalSmiles":"COC(=O)/C=C/C(=O)O","inchiKey":"NKHAVTQWNUWKEO-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOMETHYL FUMARATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bafiertam"],"synonyms":["Fumaric acid monomethyl ester","Methyl Fumarate","Monomethyl fumarate"],"crossReferences":{"drugbank":["DB14219"]},"count":1,"approvedIndications":["EFO_0003885"],"linkedTargets":{"rows":["ENSG00000079999"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003929"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for multiple sclerosis."}
{"id":"CHEMBL603830","canonicalSmiles":"CCCOc1cc([C@]2(C)CNC(=O)O2)ccc1OC","inchiKey":"PCCPERGCFKIYIS-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAXALIPRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daxalipram","[R]-Mesopram"],"crossReferences":{"drugbank":["DB01647"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL65553","canonicalSmiles":"C=CCN(C)C/C=C/COc1ccc2c(-c3ccc(Br)cc3)coc2c1","inchiKey":"KCNKJCHARANTIP-SNAWJCMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL65553","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03771"]},"childChemblIds":["CHEMBL481811"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL68055","canonicalSmiles":"CC1=C(c2ccc(O)cc2)[C@H](c2ccc(OCCN3CCCCC3)cc2)Oc2cc(O)ccc21","inchiKey":"DUYNJNWVGIWJRI-LJAQVGFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOLBIFENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acolbifene","Em-652","SCH-57068","SCH57068"],"childChemblIds":["CHEMBL2105965"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL70","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5","inchiKey":"BQJCRHHNABKAKU-KBQPJGBKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MORPHINE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Avinza","Depodur","Hydromorphone hydrochloride impurity, morphine-","IDS-NM-009","Infumorph","Kadian","Morphine","N02AA01"],"crossReferences":{"DailyMed":["morphine%20sulfate"],"Wikipedia":["Morphine"],"drugbank":["DB00295"],"chEBI":["17303"]},"childChemblIds":["CHEMBL2096625","CHEMBL4068407","CHEMBL2103744","CHEMBL556578"],"count":35,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0024647","EFO_0003777","HP_0000989","EFO_0001361","EFO_0000540","HP_0011868","HP_0004798","EFO_1001951","EFO_0003913","EFO_0003964","EFO_0009727","EFO_0003931","EFO_0002506","EFO_0009513","EFO_1000786","EFO_0004253","EFO_1001134","EFO_1001898","EFO_0004616","HP_0003419","HP_0008419","EFO_0005799","EFO_0003877","EFO_1001250","EFO_0005762","EFO_0001074","HP_0012532","EFO_0005323","MONDO_0008315","HP_0100806","MP_0001914","EFO_0000546","MONDO_0001208","HP_0003040","EFO_0009688","EFO_0009842","EFO_0004888","EFO_0000341","EFO_0005672","EFO_1001792","MONDO_0000726","EFO_0004240","EFO_1001998","Orphanet_232","EFO_0000768","EFO_0004992","MONDO_0007254","EFO_0009267","MONDO_0004565","EFO_0002950","MONDO_0001056","EFO_0005279","EFO_0003917","HP_0001822","EFO_0000616","EFO_0004210","EFO_0001645","HP_0011110","EFO_0000222","HP_0003418","EFO_0010702","EFO_0003818","EFO_0001073","EFO_0003843","HP_0002315","EFO_0005755","EFO_0000311","EFO_0007149","EFO_1001412","EFO_0004273","EFO_0008583","EFO_0000612","EFO_0005611","EFO_0003766","EFO_0009314","EFO_0004270","GO_0035483","EFO_0003918","EFO_0003833","MONDO_0024880","HP_0002019"],"count":81},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for pain and has 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL7413","canonicalSmiles":"C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O","inchiKey":"NZXKDOXHBHYTKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHOHEXITAL","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methohexital","Methohexitone"],"crossReferences":{"DailyMed":["methohexital%20sodium"],"Wikipedia":["Methohexital"],"drugbank":["DB00474"],"chEBI":["102216"]},"childChemblIds":["CHEMBL30219"],"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0002050","EFO_0003761"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960. This drug has a black box warning from the FDA."}
{"id":"CHEMBL750","canonicalSmiles":"N=S(=O)(O)Cc1noc2ccccc12","inchiKey":"UBQNRHZMVUUOMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZONISAMIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zonegran","Zonisamide"],"synonyms":["AD-810","CI-912","PD-110843","Zonisamide"],"crossReferences":{"DailyMed":["zonisamide"],"PubChem":["144205122","49666067","90341782"],"Wikipedia":["Zonisamide"],"drugbank":["DB00909"],"chEBI":["10127"]},"childChemblIds":["CHEMBL1514931","CHEMBL1596271"],"count":16,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0005203","EFO_0004566","EFO_1000877","EFO_0002610","EFO_0002508","EFO_0003821","EFO_0003768","HP_0001250","EFO_0001073","EFO_0003829","MONDO_0002046","EFO_0000474","EFO_0000289","Orphanet_36899","EFO_1001254","HP_0001300","EFO_0000692","EFO_0003108","EFO_0005411"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for epilepsy and has 15 investigational indications."}
{"id":"CHEMBL78755","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(S(N)(=O)=O)cc2)cc1","inchiKey":"HDCXQTPVTAIPNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL78755","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08301"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7942","canonicalSmiles":"O=C(O)CC(=O)O","inchiKey":"OFOBLEOULBTSOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207732"],"Wikipedia":["Malonic_acid"],"drugbank":["DB02175"],"chEBI":["30794"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL82411","canonicalSmiles":"O=C(O)Cc1c[nH]c2ccccc12","inchiKey":"SEOVTRFCIGRIMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOLE-3-ACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indole-3-Acetic Acid"],"crossReferences":{"PubChem":["144209482","144213048"],"Wikipedia":["Indole-3-acetic_acid"],"drugbank":["DB07950"],"chEBI":["16411"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL8809","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC","inchiKey":"WAOQONBSWFLFPE-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACLOPRIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Raclopride"],"crossReferences":{"PubChem":["11114224","144204512","170466218","26719717","26752250","90340860"],"Wikipedia":["Raclopride"],"drugbank":["DB12518"]},"childChemblIds":["CHEMBL1369632","CHEMBL2104769"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL917","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F","inchiKey":"ODKNJVUHOIMIIZ-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLOXURIDINE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["F.u.d.r.","Floxuridine","Fudr"],"synonyms":["5-Fluoro-2-deoxyuridine","FUDR","Floxuridine","Fluoruridine deoxyribose","NSC-27640"],"crossReferences":{"DailyMed":["floxuridine"],"PubChem":["124886843","144204443","170465247","29215018","29215019","50104188","855946","93576919"],"Wikipedia":["Floxuridine"],"drugbank":["DB00322"],"chEBI":["60761"]},"count":19,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000365","EFO_0000503","MONDO_0015686","MONDO_0008170","MONDO_0000956","Orphanet_44890","EFO_1000657","MONDO_0007576","MONDO_0021063","EFO_0004243","MONDO_0002087","EFO_0005221","EFO_1001951","EFO_1001961","EFO_0000311","MONDO_0002691","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_0000182","EFO_0004142","MONDO_0024880"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for cancer and neoplasm and has 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL9306","canonicalSmiles":"O=C([O-])[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21.[Li+]","inchiKey":"JMRXTGCDVQLAFM-JSYANWSFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"LITHIUM CLAVULANATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL777","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205100"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL94417","canonicalSmiles":"O=C1NCc2c(-c3ccc(F)cc3F)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl","inchiKey":"YAWZIQKDHQIHOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL94417","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02873"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
